Indication
Treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.

Medicine details

Medicine name:
oritavancin (Orbactiv)
SMC ID:
1112/15
Pharmaceutical company
The Medicines Company
BNF chapter
Infections
Submission type
Full
Status
Advice due date:
TBC
SMC meeting date:
01 December 2015
Patient group submission deadline:
02 November 2015